Literature DB >> 6147188

Prostatic adenocarcinoma with carcinoidal features producing adrenocorticotropic syndrome. Immunohistochemical study and review of the literature.

V S Ghali, R L Garcia.   

Abstract

An autopsy case of disseminated, military-type, composite adenocarcinoma and carcinoid tumor associated with adrenocorticotropic syndrome is discussed. Prostatic origin and functional activity were demonstrated by immunohistochemical techniques. Of interest in this case is that the tumor had the characteristics of amine precursor uptake and decarboxylation (APUD) cells and also kept the antigenicity of its prostatic origin. The APUD system perhaps should be considered as one form of functional differentiation of cells of different origin rather than an exclusive derivative of the neural crest.

Entities:  

Mesh:

Year:  1984        PMID: 6147188     DOI: 10.1002/1097-0142(19840915)54:6<1043::aid-cncr2820540619>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  Paraneoplastic syndromes in prostate cancer.

Authors:  Matthew K Hong; Jennifer Kong; Benjamin Namdarian; Anthony Longano; Jeremy Grummet; Christopher M Hovens; Anthony J Costello; Niall M Corcoran
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

2.  Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model.

Authors:  Srinivas Nandana; Katharine Ellwood-Yen; Charles Sawyers; Marcia Wills; Brandy Weidow; Thomas Case; Valeri Vasioukhin; Robert Matusik
Journal:  Prostate       Date:  2010-05-01       Impact factor: 4.104

3.  Prostatic adenocarcinoma evolving into carcinoid: selective effect of hormonal treatment?

Authors:  M Stratton; D J Evans; I A Lampert
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

4.  Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.

Authors:  Jonathan I Epstein; Mahul B Amin; Himisha Beltran; Tamara L Lotan; Juan-Miguel Mosquera; Victor E Reuter; Brian D Robinson; Patricia Troncoso; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

5.  Calcitonin immunoreactive cells in prostate gland and cloacal derived tissues.

Authors:  F Fetissof; G Bertrand; D Guilloteau; M P Dubois; Y Lanson; B Arbeille
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 6.  Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate.

Authors:  M A Noordzij; G J van Steenbrugge; T H van der Kwast; F H Schröder
Journal:  Urol Res       Date:  1995

7.  Establishing prostate cancer patient derived xenografts: lessons learned from older studies.

Authors:  Pamela J Russell; Peter Russell; Christina Rudduck; Brian W C Tse; Elizabeth D Williams; Derek Raghavan
Journal:  Prostate       Date:  2015-01-05       Impact factor: 4.104

8.  An Unusual Case of Resistant Hypokalaemia in a Patient with Large Bowel Obstruction Secondary to Neuroendocrine Carcinoma of the Prostate.

Authors:  Umasankar Mathuram Thiyagarajan; A Ponnuswamy; A Bagul; A Gupta
Journal:  Case Rep Surg       Date:  2017-03-13

Review 9.  Severe Cushing's syndrome due to small cell prostate carcinoma: a case and review of literature.

Authors:  M S Elston; V B Crawford; M Swarbrick; M S Dray; M Head; J V Conaglen
Journal:  Endocr Connect       Date:  2017-06-05       Impact factor: 3.335

10.  ECTOPIC ADRENOCORTICOTROPIC HORMONE SYNDROME DUE TO METASTATIC PROSTATE CANCER WITH NEUROENDOCRINE DIFFERENTIATION.

Authors:  Malini Soundarrajan; Henry Zelada; Jean Victoria Fischer; Peter Kopp
Journal:  AACE Clin Case Rep       Date:  2019-04-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.